Emmanuel E. Egom
Hartford Hospital(US)Institut de Recherches Médicales et d’Etudes des Plantes Médicinales(CM)Institut du Savoir Montfort(CA)
Publications by Year
Research Areas
Sphingolipid Metabolism and Signaling, Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Cardiac electrophysiology and arrhythmias, Pulmonary Hypertension Research and Treatments
Most-Cited Works
- → The potential actions of angiotensin‐converting enzyme II (ACE2) activator diminazene aceturate (DIZE) in various diseases(2020)98 cited
- → FTY720 prevents ischemia/reperfusion injury-associated arrhythmias in an ex vivo rat heart model via activation of Pak1/Akt signaling(2009)95 cited
- → Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury(2011)92 cited
- → Impaired sinoatrial node function and increased susceptibility to atrial fibrillation in mice lacking natriuretic peptide receptor C(2014)69 cited
- → Loss of insulin signaling may contribute to atrial fibrillation and atrial electrical remodeling in type 1 diabetes(2020)69 cited
- → Markers of Atherosclerosis: Part 1 – Serological Markers(2018)68 cited